Dianthus Therapeutics, Inc. /DE/ financial data

Symbol
DNTH on Nasdaq
Industry
Pharmaceutical Preparations
Location
300 Technology Square, 8 Th Floor, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Magenta Therapeutics, Inc. (to 9/8/2023)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.73K % +96.5%
Debt-to-equity 3.83 % -97.5%
Return On Equity -21.7 % +97.3%
Return On Assets -20.9 % +47%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29.6M shares +99.7%
Common Stock, Shares, Outstanding 29.4M shares +98.2%
Entity Public Float 32.1M USD
Common Stock, Value, Issued 29K USD +93.3%
Weighted Average Number of Shares Outstanding, Basic 34.2M shares +776%
Weighted Average Number of Shares Outstanding, Diluted 34.2M shares +776%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 924K USD -21.2%
Research and Development Expense 65.5M USD +262%
General and Administrative Expense 22.8M USD +431%
Operating Income (Loss) -82.9M USD -462%
Nonoperating Income (Expense) 15.8M USD +374%
Net Income (Loss) Attributable to Parent -67.1M USD -55.6%
Earnings Per Share, Basic 14.4 USD/shares +80.4%
Earnings Per Share, Diluted 14.4 USD/shares +80.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 33.7M USD -78.6%
Marketable Securities, Current 54.4M USD +20.2%
Accounts Receivable, after Allowance for Credit Loss, Current 1.39M USD +499%
Other Assets, Current 53K USD +430%
Assets, Current 287M USD +50.2%
Property, Plant and Equipment, Net 189K USD -3.08%
Operating Lease, Right-of-Use Asset 352K USD -49.6%
Assets 354M USD +84.1%
Accounts Payable, Current 7.57M USD +453%
Employee-related Liabilities, Current 4.01M USD -9.48%
Accrued Liabilities, Current 7.73M USD -31%
Liabilities, Current 15.7M USD +20.1%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 16.4M USD +16.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 681K USD
Retained Earnings (Accumulated Deficit) -146M USD -85.1%
Stockholders' Equity Attributable to Parent 338M USD +89.4%
Liabilities and Equity 354M USD +84.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.9M USD -45.3%
Net Cash Provided by (Used in) Financing Activities 218M USD
Net Cash Provided by (Used in) Investing Activities -5.51M USD -130%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 29.4M shares +98.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 197M USD +2416%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 33.9M USD -78.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 123M USD +967%
Deferred Tax Assets, Gross 137M USD +1063%
Operating Lease, Liability 311K USD -53.6%
Depreciation 89K USD +31.6%
Payments to Acquire Property, Plant, and Equipment 245K USD +807%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -66.4M USD -421%
Lessee, Operating Lease, Liability, to be Paid 328K USD -55.7%
Property, Plant and Equipment, Gross 356K USD +30.9%
Operating Lease, Liability, Current 311K USD -24.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 222K USD -39.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 222K USD -46.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 17K USD -76.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 188K USD
Deferred Tax Assets, Operating Loss Carryforwards 73.6M USD +1267%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.06M USD
Operating Lease, Payments 19.8M USD -100%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 7.31M USD +14.7%
Depreciation, Depletion and Amortization 421K USD -17.6%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 6.94M USD
Deferred Tax Assets, Net of Valuation Allowance 13.3M USD +6690%
Share-based Payment Arrangement, Expense 9.7M USD +226%
Operating Leases, Future Minimum Payments, Due in Three Years 7.68M USD +14%
Operating Leases, Future Minimum Payments Due 44.9M USD -9.73%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%